Overview

Safety and Efficacy of Oral Febuxostat in Subjects With Gout

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare febuxostat allopurinol in subjects with gout.
Phase:
Phase 3
Details
Lead Sponsor:
Xijing Hospital
Collaborator:
Qingdao Shengbang Pharmaceutical Co., Ltd.
Treatments:
Allopurinol
Febuxostat